Literature DB >> 4573205

Effect of vitamin D on bone mineral mass in normal subjects and in epileptic patients on anticonvulsants: a controlled therapeutic trial.

C Christiansen, P Rodbro, M Lund.   

Abstract

The bone mineral mass was estimated by photon absorptiometry in 23 epileptic patients on long-term treatment with phenytoin and in 20 normal subjects before and during treatment with vitamin D or placebo.Initially, subnormal values of bone mineral mass were found in the epileptic patients. The group of epileptic patients treated with vitamin D showed a significant increase in bone mineral mass. The group of epileptic patients treated with placebo and the normal subjects treated with vitamin D or placebo showed no change in bone mineral mass.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4573205      PMCID: PMC1589361          DOI: 10.1136/bmj.2.5860.208

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  The mineral content in bone. Measured by means of 27.5 keV radiation from 125I.

Authors:  H Jensen; C Christiansen; I F Lindbjerg; O Munck
Journal:  Acta Radiol Suppl       Date:  1972

2.  [Osteopathies in antiepileptic long-term therapy (preliminary report)].

Authors:  R Kruse
Journal:  Monatsschr Kinderheilkd       Date:  1968-06

3.  Latent osteomalacia in epileptic patients on anticonvulsants.

Authors:  C Christiansen; M Kristensen; P Rodbro
Journal:  Br Med J       Date:  1972-09-23

4.  Rapid determination of serum diphenylhydantoin by gas chromatography.

Authors:  N E Larsen
Journal:  Med Lab Technol       Date:  1971-10

5.  Bone density in patients receiving long-term anticonvulsant therapy.

Authors:  J Linde; J Molholm Hansen; K Siersbaek-Nielsen; V Fuglsang-Fredriksen
Journal:  Acta Neurol Scand       Date:  1971       Impact factor: 3.209

6.  Precision and accuracy of bone mineral determination by direct photon absorptiometry.

Authors:  J R Cameron; R B Mazess; J A Sorenson
Journal:  Invest Radiol       Date:  1968 May-Jun       Impact factor: 6.016

7.  Disturbance of calcium metabolism by anticonvulsant drugs.

Authors:  A Richens; D J Rowe
Journal:  Br Med J       Date:  1970-10-10

8.  [Bone structure changes in long-term anticonvulsant treatment].

Authors:  G Berger; B Munde
Journal:  Dtsch Gesundheitsw       Date:  1970-08-13

9.  Osteomalacia with long-term anticonvulsant therapy in epilepsy.

Authors:  C E Dent; A Richens; D J Rowe; T C Stamp
Journal:  Br Med J       Date:  1970-10-10

10.  Altered calcium metabolism in epileptic children on anticonvulsants.

Authors:  J Hunter; J D Maxwell; D A Stewart; V Parsons; R Williams
Journal:  Br Med J       Date:  1971-10-23
  10 in total
  7 in total

1.  The clinical consequences of chronic hepatic enzyme induction by anticonvulsant drugs.

Authors:  A Richens
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

2.  Anticonvulsant osteomalacia.

Authors: 
Journal:  Br Med J       Date:  1976-12-04

3.  Incidence of anticonvulsant osteomalacia and effect of vitamin D: controlled therapeutic trial.

Authors:  C Christiansen; P Rodbro; M Lund
Journal:  Br Med J       Date:  1973-12-22

4.  [The frequency of adult anticonvulsant osteomalacia in relation to duration of therapy and dosage of anticonvulsants (author's transl)].

Authors:  U Mehregan; K H Krause; P Prager
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979-04-12

5.  Low dose phenytoin is an osteogenic agent in the rat.

Authors:  T Ohta; J E Wergedal; H E Gruber; D J Baylink; K H Lau
Journal:  Calcif Tissue Int       Date:  1995-01       Impact factor: 4.333

6.  Bone mineral status measured by direct photon absorptiometry in institutionalized adults receiving long-term anticonvulsant therapy and multivitamin supplementation.

Authors:  H S Barden; R B Mazess; P G Rose; W McAweeney
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

Review 7.  Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy.

Authors:  Peter Vestergaard
Journal:  Paediatr Drugs       Date:  2015-04       Impact factor: 3.022

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.